Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?

To: mike head who wrote (483)	3/7/1999 5:05:00 PM
From: scaram(o)uche	Respond to of 4974

Keep this type of article rolling in! (eom)

To: mike head who wrote (483)	3/7/1999 6:21:00 PM
From: Mike McFarland	Read Replies (2) \| Respond to of 4974

the scientists used molecular probes to highlight and compare the gene activity in cancer patients' normal prostate tissue with that of their tumours Found this at the Sixth Annual HUMAN GENOME PROJECT: Commercial Implications (March 1-3, 1999) healthtech.com ...from the afternoon sesssion-- EXPRESSION PROFILING: EXTRACTING VALUE 1:50 Large-Scale Screen of Gene Expression Patterns in Epithelial Tumors Dr. Lewis T. Williams, Chief Scientific Officer, Chiron Corporation We have used a novel hybridization technology for identifying differentially expressed genes in breast, lung, prostrate, colon and ovarian cancers. The focus of these experiments has been an expression pattern of highly metastic versus non-mestastic cancer cells and normal versus cancer tissue. We have also developed arrays containing a large number of novel probes and are using these to screen hundreds of laser microdissected specimens. ______ I guess it's no surprise that Chiron is right there-- although I am not sure if this is precisely the same sort of thing the John Hopkins researchers are doing... --MM